Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...

This project is a proof-of-concept that runs a JavaScript engine inside a web browser by compiling it to WebAssembly. The engine is Goja — a pure-Go implementation of ECMAScript 5.1 — and the ...

News is breaking today that Replimune Group, Inc.'s (REPL) Biologics License Application ("BLA") requesting approval for its drug candidate RP1 (vusolimogene oderparepvec) in the indication of anti-PD ...

FDA issued a second complete response letter denying approval for Replimune’s RP1 melanoma immunotherapy The treatment was under review for use with Bristol Myers Squibb’s (BMY) Opdivo Regulatory ...

This story contains AI-generated text. The author has used AI either for research, to generate outlines, or write the text itself. While learning data science with Python, one library impressed me ...

News publishers overloading their sites with ads, plus the ever-growing technical requirements for running ad auctions, have given rise to a new online phenomenon ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Google has removed a whole section from its JavaScript SEO documentation because it was outdated and Google says loading content with JavaScript does not make it hard for Google Search. Google wrote ...

A "coordinated developer-targeting campaign" is using malicious repositories disguised as legitimate Next.js projects and technical assessments to trick victims into executing them and establish ...

Strip the types and hotwire the HTML—and triple check your package security while you are at it. JavaScript in 2026 is just getting started. I am loath to inform you that the first month of 2026 has ...